netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Introduction

Welcome to the Leeds Medicines Formulary

Useful Links

meandmymedicines

 Adult BNF
 Paediatric BNF
BNF Apps (iOS and Android) 

Further Medicines Management Resources

NHS Leeds Traffic Light List

Antimicrobial guidelines

Compliance with NICE technology appraisals

 

News Feed

MHRA: Drug Safety Update (August 2018): Esmya (ulipristal acetate) risk of serious liver injury: new restrictions to use and requirements for liver function monitoring before, during, and after treatment


MHRA: Drug Safety Update (July 2018): Parenteral amphotericin B: risk of potentially fatal adverse reaction if formulations confused


MHRA: Drug Safety Update (July 2018): Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results


MHRA: Drug Safety Update (July 2018): Darunavir boosted with cobicistat: avoid use in pregnancy


MHRA: Drug Safety Update (June 2018): Denosumab (Xgeva▼) for advanced malignancies involving bone


MHRA: Drug Safety Update (June 2018): Denosumab (Xgeva) for giant cell tumour of bone: risk of clinically significant hypercalcaemia following discontinuation


>>> more news

Leeds Secondary Care Links

LTHT Injectable Medicines Guides (Medusa)
Adult IV monographs
Paediatric IV monographs

 


NetFormulary
   Last updated: 24/09/2018 15:29:43